Carrie Yeung 1 ,
Teresa M Petrella 2 ,
Frances C Wright 3 ,
Wadid Abadir 4 ,
Nicole J Look Hong 3
Publication date (Electronic): Apr 2017
Journal: Expert review of clinical immunology
Publisher: Informa UK Limited
Keywords: Diphencyprone, immunotherapy, in-transit metastasis, melanoma, toxicity
Diphencycprone (DPCP) is an immune contact sensitizer applied to melanoma lesions.
Early studies show favorable efficacy. We present the first North-American series
of patients treated with DPCP.